Cigna director defers pay into phantom units

The Cigna Group director George Kurian increased his deferred compensation stake through a grant of phantom stock units.

Rhea-AI Filing Summary

The Cigna Group director George Kurian increased his deferred compensation stake through a grant of phantom stock units. On this Form 4, he acquired 103.5125 phantom stock units on February 27, 2026 as a grant, bringing his total phantom stock unit holdings to 1,803.6672.

The units reflect a voluntary deferral of a portion of his cash retainer into a hypothetical stock fund under Cigna’s Deferred Compensation Plan of 2005 for directors. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. The total includes 9.3181 phantom stock units credited through a dividend reinvestment feature of the plan.

Insider Trade Summary

Grant/Award: 103.5125 shares

Grant/Award 1 txn

Insider Kurian George

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	103.5125	$289.82	$30K

Holdings After Transaction: Phantom Stock Units — 1,803.6672 contracts (Direct)

Footnotes (2)

1. F1. Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.
2. F2. Includes 9.3181 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

FAQ

What insider transaction did Cigna (CI) director George Kurian report?

George Kurian reported acquiring phantom stock units as deferred compensation. He received 103.5125 units on February 27, 2026, under Cigna’s Deferred Compensation Plan of 2005 for directors, increasing his total phantom stock unit holdings to 1,803.6672.

How many phantom stock units does Cigna (CI) director George Kurian now hold?

After the reported transaction, George Kurian holds 1,803.6672 phantom stock units. This total reflects the February 27, 2026 grant of 103.5125 units and prior accumulations, including additional units credited through the plan’s dividend reinvestment feature.

What are phantom stock units in Cigna’s (CI) director compensation plan?

Phantom stock units in Cigna’s director plan are bookkeeping entries tied to the company’s stock price. Each unit equals one Cigna common share economically but will be settled in cash, allowing directors to defer compensation without receiving actual stock or voting rights.

How did George Kurian’s phantom stock units arise under Cigna’s (CI) Deferral Plan?

Kurian’s phantom stock units arise from voluntarily deferring part of his cash retainer into a hypothetical stock fund. Under Cigna’s Deferred Compensation Plan of 2005 for directors, his deferred amounts convert into phantom stock units that mirror Cigna’s stock performance and are ultimately settled in cash.

Did dividend reinvestment affect George Kurian’s Cigna (CI) phantom stock units?

Yes. The disclosure states his total includes 9.3181 phantom stock units acquired through a dividend reinvestment feature. This means dividends credited under the Deferred Compensation Plan were automatically converted into additional phantom stock units instead of being paid in cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kurian George

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	(1)	02/27/2026		A		103.5125		(1)	(1)	Common Stock, $.01 Par Value	103.5125	$289.82	1,803.6672	D(2)

Explanation of Responses:

1. Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

2. Includes 9.3181 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Remarks:

	Tyler Gratton, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.